Middle East & Africa Crispr And Cas Genes Market Size & Outlook

The crispr and cas genes market in Middle East & Africa is expected to reach a projected revenue of US$ 180.8 million by 2030. A compound annual growth rate of 15.3% is expected of Middle East & Africa crispr and cas genes market from 2024 to 2030.
Revenue, 2023 (US$M)
$66.8
Forecast, 2030 (US$M)
$180.8
CAGR, 2024 - 2030
15.3%
Report Coverage
Middle East & Africa

MEA crispr and cas genes market highlights

  • The MEA crispr and cas genes market generated a revenue of USD 66.8 million in 2023.
  • The market is expected to grow at a CAGR of 15.3% from 2024 to 2030.
  • In terms of segment, product was the largest revenue generating product & service in 2023.
  • Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
  • Country-wise, Saudi Arabia is expected to register the highest CAGR from 2024 to 2030.


MEA data book summary

Market revenue in 2023USD 66.8 million
Market revenue in 2030USD 180.8 million
Growth rate15.3% (CAGR from 2023 to 2030)
Largest segmentProduct
Fastest growing segmentService
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationProduct, Service
Key market players worldwideAstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics


Other key industry trends

  • In terms of revenue, MEA region accounted for 2.1% of the global crispr and cas genes market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,461.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

CRISPR And Cas Genes Market Companies

Name Profile # Employees HQ Website

Middle East & Africa crispr and cas genes market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to crispr and cas genes market will help companies and investors design strategic landscapes.


Product was the largest segment with a revenue share of 78.29% in 2023. Horizon Databook has segmented the Middle East & Africa crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.


This region was observed to have the lowest market penetration in 2019. However, in the coming years, the MEA market is expected to witness considerable growth, owing to the growing importance of CRISPR technologies in human disease treatment.

Moreover, clinical studies conducted on the use of gene-editing in agriculture is expected to impact the growth of MEA’s GM crop industry. Researchers are continuously employing this technology for the development of novel therapies.

In May 2018, researchers from the United Arab Emirates University successfully used CRISPRCas9 technology to gain insights on disease mechanisms, finally helping them design novel therapies. The UAE ranks sixth in the globe in terms of prevalence of birth defects, which is expected to propel the demand for novel therapies.

Reasons to subscribe to Middle East & Africa crispr and cas genes market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa crispr and cas genes market databook

  • Our clientele includes a mix of crispr and cas genes market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa crispr and cas genes market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa crispr and cas genes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA crispr and cas genes market size, by country, 2018-2030 (US$M)

Middle East & Africa CRISPR And Cas Genes Market Outlook Share, 2023 & 2030 (US$M)

MEA crispr and cas genes market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more